针对下丘脑的AgRP神经元中的Gβγ子单元来治疗肥胖症
Ye Xuan1, Xiaoyue Xiong1, Xinyu Wang1
1State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Department of Endocrinology and Metabolism, Shanghai Diabetes Institute, Shanghai Clinical Center for Diabetes, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
Metabolism: clinical and experimental
|February 21, 2026
概括
下丘脑中的G蛋白β玛 (Gβγ) 子单元调节食欲和新陈代谢. 通过素抑制Gβγ可以减少食物摄入量,并通过抑制Agouti相关神经元活动来改善饮食引起的肥胖症.
科学领域:
- 神经科学是一个神经科学.
- 代谢障碍 代谢障碍 代谢障碍
- 药理学 药理学是指药理学的学科.
背景情况:
- 下丘脑中的G蛋白结合受体 (GPCR) 是肥胖治疗的点,但副作用限制了药物开发.
- 针对GPCRs下游的G蛋白子单元提供了一个替代策略来偏向信号通路.
- 在肥胖中G蛋白βγ (Gβγ) 子单元的作用仍然在很大程度上未被探索.
研究的目的:
- 研究Gβγ亚单元在饮食引起的肥胖 (DIO) 和相关的代谢功能障碍中的作用.
- 确定Gβγ抑制是否可以改善DIO并抑制食欲.
- 阐明Gβγ子单元调节下丘脑能量平衡的机制.
主要方法:
- 给饮食诱导肥胖的小鼠,给予一种Gβγ抑制剂莱因.
- 评估食欲,体重和代谢参数.
- 研究Gβγ亚单元对下丘脑中阿古蒂相关 (AgRP) 神经元活动的影响.
- 在AgRP神经元中分析AMPK活性和线粒体生物能学.
- 在AgRP神经元中对Gβγ亚单元表达的基因操纵.
主要成果:
- 盖莱因治疗通过抑制食欲改善了DIO和代谢功能障碍.
- 盖莱因抑制了下丘脑中AgRP神经元的活性.
- 在AgRP神经元中对Gβγ的特定抑制减少了食物摄入量并改善了DIO.
- 在AgRP神经元中Gβγ的过度表达促进了过和肥胖.
- 发现Gβγ亚单元增加AMPK活性,促进线粒体脂肪酸氧化和ATP产生,从而增加AgRP神经元活性.
结论:
- Gβγ亚单元在调节AgRP神经元中的生物能量过程中,在调节养行为和新陈代谢方面发挥着关键作用.
- 抑制Gβγ亚单元代表了对肥胖和相关代谢障碍的有前途的治疗策略.
- 氨酸是一种Gβγ抑制剂,是治疗肥胖症的潜在候选药物.
相关概念视频
G Protein-coupled Receptors
18.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
18.1K
Regulation of Food Intake
3.0K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
3.0K
GPCRs Regulate Adenylyl Cylase Activity
7.7K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.7K
Glucagon-like Receptor Agonists
1.1K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.1K
GPCR Desensitization
8.4K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.4K
Transducer Mechanism: G Protein–Coupled Receptors
5.0K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
5.0K


